Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation.

作者: L A Pradelli , M Bénéteau , C Chauvin , M A Jacquin , S Marchetti

DOI: 10.1038/ONC.2009.448

关键词:

摘要: Most cancer cells exhibit increased glycolysis for generation of their energy supply. This specificity could be used to preferentially kill these cells. In this study, we identified the signaling pathway initiated by inhibition that results in sensitization death receptor (DR)-induced apoptosis. We showed, several human cell lines (such as Jurkat, HeLa, U937), glucose removal or use nonmetabolizable form (2-deoxyglucose) dramatically enhances apoptosis induced Fas tumor necrosis factor-related apoptosis-inducing ligand. is controlled through adenosine monophosphate (AMP)-activated protein kinase (AMPK), which central energy-sensing system cell. established fact AMPK activated upon block resulting mammalian target rapamycin (mTOR) leading Mcl-1 decrease, but no other Bcl-2 anti-apoptotic members. Interestingly, determined that, inhibition, AMPK-mTOR levels neither transcriptional nor posttranslational mechanism rather controlling its translation. Therefore, our show a novel DR-induced linking metabolism downexpression. addition, study provides rationale combined DR ligands with activators mTOR inhibitors treatment cancers.

参考文章(38)
H. Dorota Halicka, Zbigniew Darzynkiewicz, Barbara Ardelt, Xun Li, Myron M. Melamed, 2-Deoxy-d-Glucose Enhances Sensitivity of Human Histiocytic Lymphoma U937 Cells to Apoptosis Induced by Tumor Necrosis Factor Cancer Research. ,vol. 55, pp. 444- 449 ,(1995)
Yoshihide Tsujimoto, Yutaka Eguchi, Shigeomi Shimizu, Intracellular ATP levels determine cell death fate by apoptosis or necrosis Cancer Research. ,vol. 57, pp. 1835- 1840 ,(1997)
J L Mott, S Kobayashi, S F Bronk, G J Gores, mir-29 regulates Mcl-1 protein expression and apoptosis Oncogene. ,vol. 26, pp. 6133- 6140 ,(2007) , 10.1038/SJ.ONC.1210436
Maggie M-Y Chi, Joyce Pingsterhaus, Mary Carayannopoulos, Kelle H. Moley, Decreased glucose transporter expression triggers BAX-dependent apoptosis in the murine blastocyst. Journal of Biological Chemistry. ,vol. 275, pp. 40252- 40257 ,(2000) , 10.1074/JBC.M005508200
Guo Wei, David Twomey, Justin Lamb, Krysta Schlis, Jyoti Agarwal, Ronald W. Stam, Joseph T. Opferman, Stephen E. Sallan, Monique L. den Boer, Rob Pieters, Todd R. Golub, Scott A. Armstrong, Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance Cancer Cell. ,vol. 10, pp. 331- 342 ,(2006) , 10.1016/J.CCR.2006.09.006
Carsten Scaffidi, Ingo Schmitz, Jiping Zha, Stanley J. Korsmeyer, Peter H. Krammer, Marcus E. Peter, Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells Journal of Biological Chemistry. ,vol. 274, pp. 22532- 22538 ,(1999) , 10.1074/JBC.274.32.22532
K Takeda, J Stagg, H Yagita, K Okumura, M J Smyth, Targeting death-inducing receptors in cancer therapy. Oncogene. ,vol. 26, pp. 3745- 3757 ,(2007) , 10.1038/SJ.ONC.1210374
Cristina Muñoz-Pinedo, Carmen Ruiz-Ruiz, Carmen Ruiz de Almodóvar, Carmen Palacios, Abelardo López-Rivas, Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signaling complex formation and apical procaspase-8 processing. Journal of Biological Chemistry. ,vol. 278, pp. 12759- 12768 ,(2003) , 10.1074/JBC.M212392200
Magali Herrant, Arnaud Jacquel, Sandrine Marchetti, Nathalie Belhacène, Pascal Colosetti, Frédéric Luciano, Patrick Auberger, Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis. Oncogene. ,vol. 23, pp. 7863- 7873 ,(2004) , 10.1038/SJ.ONC.1208069
MN Corradetti, KL Guan, None, Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene. ,vol. 25, pp. 6347- 6360 ,(2006) , 10.1038/SJ.ONC.1209885